time_published,title,sentiment_score,sentiment_label,ticker
2025-11-10 12:29:00,Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit - Vera Therapeutics  ( NASDAQ:VERA ) ,0.0716,Neutral,VERA
2025-11-07 23:27:20,Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy - Vera Therapeutics  ( NASDAQ:VERA ) ,0.16181,Somewhat-Bullish,VERA
2025-11-07 23:27:00,Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy,0.168924,Somewhat-Bullish,VERA
2025-11-07 21:05:00,Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.23144,Somewhat-Bullish,VERA
2025-11-07 21:05:00,Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Vera Therapeutics  ( NASDAQ:VERA ) ,0.208084,Somewhat-Bullish,VERA
2025-11-06 14:51:00,Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine,0.167261,Somewhat-Bullish,VERA
2025-11-05 12:29:00,Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results,0.152578,Somewhat-Bullish,VERA
2025-10-27 15:15:34,"Capricorn Fund Loads Up on Phreesia  ( PHR )  With a 484,000 Share Purchase",0.268828,Somewhat-Bullish,VERA
2025-10-17 13:12:19,Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025 - Vera Therapeutics  ( NASDAQ:VERA ) ,0.141418,Neutral,VERA
2025-10-17 13:12:00,Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025,0.150974,Somewhat-Bullish,VERA
2025-10-16 18:17:37,Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market - Vera Therapeutics  ( NASDAQ:VERA ) ,0.21179,Somewhat-Bullish,VERA
2025-10-16 12:50:15,"This Celestica Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Climb Bio  ( NASDAQ:CLYM ) , Celestica  ( NYSE:CLS ) ",0.202832,Somewhat-Bullish,VERA
2025-10-10 20:05:00,Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.227516,Somewhat-Bullish,VERA
2025-09-30 13:11:43,"6 Stocks Poised For Potential Acquisition In The Next 12 Months, According To Goldman Sachs, Including A 200% YTD Gainer -  ( AACT ) , Walt Disney  ( NYSE:DIS ) ",0.229373,Somewhat-Bullish,VERA
2025-09-05 20:05:00,Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.215868,Somewhat-Bullish,VERA
2025-08-26 20:05:00,Vera Therapeutics to Participate at Upcoming Investor Conferences,0.028866,Neutral,VERA
2025-08-08 20:05:00,Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.222888,Somewhat-Bullish,VERA
2025-08-06 06:05:25,Vera  ( VERA )  Q2 Net Loss Widens 127%,0.217615,Somewhat-Bullish,VERA
2025-08-04 11:47:31,"This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Allogene Therapeutics  ( NASDAQ:ALLO ) , AvalonBay Communities  ( NYSE:AVB ) ",0.189998,Somewhat-Bullish,VERA
2025-07-10 23:05:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.227545,Somewhat-Bullish,VERA
2025-06-09 20:05:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.229819,Somewhat-Bullish,VERA
2025-06-06 16:17:36,"Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results - ABM Indus  ( NYSE:ABM ) , Docusign  ( NASDAQ:DOCU ) ",0.222083,Somewhat-Bullish,VERA
2025-06-06 13:54:18,"Dow Jumps Over 500 Points; Nonfarm Payrolls Top Estimates - Davis Commodities  ( NASDAQ:DTCK ) , EPWK Holdings  ( NASDAQ:EPWK ) ",0.290519,Somewhat-Bullish,VERA
2025-06-06 12:25:40,"Lululemon Cuts Earnings Forecast, Joins DocuSign, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Braze  ( NASDAQ:BRZE ) , Docusign  ( NASDAQ:DOCU ) ",0.061,Neutral,VERA
2025-06-02 16:49:43,"Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Applied Digital  ( NASDAQ:APLD ) , Lyra Therapeutics  ( NASDAQ:LYRA ) ",-0.014573,Neutral,VERA
2025-06-02 13:01:22,"Vera Therapeutics Releases Trial Data, Stock Price Soars - Vera Therapeutics  ( NASDAQ:VERA ) ",0.187068,Somewhat-Bullish,VERA
2025-06-02 10:30:00,Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy - Vera Therapeutics  ( NASDAQ:VERA ) ,0.137002,Neutral,VERA
2025-06-02 10:30:00,Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy,0.13246,Neutral,VERA
2025-05-09 20:05:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Vera Therapeutics  ( NASDAQ:VERA ) ,0.233951,Somewhat-Bullish,VERA
2025-04-09 20:05:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Vera Therapeutics  ( NASDAQ:VERA ) ,0.233951,Somewhat-Bullish,VERA
2025-04-09 18:51:39,"Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Vera Therapeutics  ( NASDAQ:VERA ) ",0.178654,Somewhat-Bullish,VERA
2025-03-26 17:35:02,"Nephrologists Embrace Earlier, More Aggressive IgAN Treatment as Branded Therapies from Calliditas, Travere, and Novartis Continue to Gain Traction, According to Spherix Global Insights",0.336595,Somewhat-Bullish,VERA
2025-03-11 20:28:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.216155,Somewhat-Bullish,VERA
2025-02-27 13:00:00,Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - Vera Therapeutics  ( NASDAQ:VERA ) ,0.128361,Neutral,VERA
2025-02-26 13:25:00,Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results,0.136703,Neutral,VERA
2025-02-04 14:15:02,"This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Expand Energy  ( NASDAQ:EXE ) , Catalyst Pharmaceuticals  ( NASDAQ:CPRX ) ",0.396436,Bullish,VERA
2025-01-22 11:46:45,"Top 3 Health Care Stocks That Could Blast Off This Quarter - Vera Therapeutics  ( NASDAQ:VERA ) , RadNet  ( NASDAQ:RDNT ) ",0.166783,Somewhat-Bullish,VERA
2025-01-13 19:25:10,What's Going On With Vera Therapeutics Stock? - Vera Therapeutics  ( NASDAQ:VERA ) ,0.324916,Somewhat-Bullish,VERA
2025-01-13 12:00:00,"Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor - Vera Therapeutics  ( NASDAQ:VERA ) ",0.031476,Neutral,VERA
2025-01-07 21:05:00,Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference,0.055018,Neutral,VERA
2024-12-09 23:29:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.213621,Somewhat-Bullish,VERA
2024-11-22 21:05:00,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,0.215783,Somewhat-Bullish,VERA
2024-11-11 14:55:12,Wall Street Analysts Think Vera Therapeutics  ( VERA )  Could Surge 27.26%: Read This Before Placing a Bet,0.217849,Somewhat-Bullish,VERA
2024-11-08 21:05:00,Vera Therapeutics to Participate at Upcoming Investor Conferences,0.062396,Neutral,VERA
2024-11-08 13:00:00,Vera Therapeutics to Participate at Upcoming Investor Conferences,0.062396,Neutral,VERA
2024-11-08 13:00:00,Vera Therapeutics to Participate at Upcoming Investor Conferences - Vera Therapeutics  ( NASDAQ:VERA ) ,0.118727,Neutral,VERA
2024-10-30 00:21:45,Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - Vera Therapeutics  ( NASDAQ:VERA ) ,0.094599,Neutral,VERA
2024-10-30 00:21:00,Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock,0.080467,Neutral,VERA
2024-10-28 21:37:30,Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - Vera Therapeutics  ( NASDAQ:VERA ) ,0.080525,Neutral,VERA
2024-10-28 21:37:00,Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock,0.064023,Neutral,VERA
